File Download

There are no files associated with this item.

Supplementary

Conference Paper: Potentially malignant disorder behaviour – Proliferative Verrucous Leukoplakia vs Lichenoid Inflammation

TitlePotentially malignant disorder behaviour – Proliferative Verrucous Leukoplakia vs Lichenoid Inflammation
Authors
Issue Date2018
PublisherInternational Association for Dental Research.
Citation
The 96th General Session and Exhibition of the International Association for Dental Research (IADR) and IADR Pan European Regional (PER) Congress, London, UK, 25-28 July 2018 How to Cite?
AbstractObjectives: Clinically identifiable potentially malignant disorders (PMD) precede oral squamous cell carcinoma (OSCC). PMDs exhibiting Proliferative Verrucous Leukoplakia (PVL) or Lichenoid Inflammation (LI) are believed to exhibit treatment resistance & a higher risk of malignant transformation (MT). The objective of this study was to characterize & contrast clinico-pathological features in PVL & LI & to determine their influence on PMD behaviour. Methods: Retrospective review of 590 PMD patients treated in Northern England by CO2 laser between 1996 & 2014 with known clinical outcome. Lesions exhibiting PVL or LI were identified from a previously published database & the influence of clinico-pathological features on outcome analyzed. Results: 80 PVL & 118 LI cases were seen, predominantly leukoplakias on ventro-lateral tongue & floor of mouth, equally distributed between males & females. Most showed dysplasia on incision biopsy (85% PVL; 82% LI) & were treated by laser excision rather than ablation (86.25% PVL; 88.1% LI). LIs were more common in younger patients (PVL mean age 62.25yrs; LI mean age 57.1yrs; p=0.008) & more likely to present as erythroleukoplakia (PVL 2.5%; LI 15.3%; p=0.003). No significant clinical outcome differences were seen with 65% PVL & 69.5% LI disease free at study census (p=0.55), although less than overall PMD disease free status (74.2%)1. 2 PVLs (2.5%) & 2 LIs (1.7%) underwent MT. Conclusions: One-third of PMD cases exhibited PVL or LI with reduced disease free status, with LIs distinguishable as erythroleukoplakia in younger patients. MT is infrequent following interventional laser excision.
Description307 - Oral and Maxillofacial Surgery I - Poster Presentation - no. 2124
Persistent Identifierhttp://hdl.handle.net/10722/258082

 

DC FieldValueLanguage
dc.contributor.authorThomson, PJ-
dc.contributor.authorGoodson, ML-
dc.contributor.authorSmith, D-
dc.date.accessioned2018-08-22T01:32:43Z-
dc.date.available2018-08-22T01:32:43Z-
dc.date.issued2018-
dc.identifier.citationThe 96th General Session and Exhibition of the International Association for Dental Research (IADR) and IADR Pan European Regional (PER) Congress, London, UK, 25-28 July 2018-
dc.identifier.urihttp://hdl.handle.net/10722/258082-
dc.description307 - Oral and Maxillofacial Surgery I - Poster Presentation - no. 2124-
dc.description.abstractObjectives: Clinically identifiable potentially malignant disorders (PMD) precede oral squamous cell carcinoma (OSCC). PMDs exhibiting Proliferative Verrucous Leukoplakia (PVL) or Lichenoid Inflammation (LI) are believed to exhibit treatment resistance & a higher risk of malignant transformation (MT). The objective of this study was to characterize & contrast clinico-pathological features in PVL & LI & to determine their influence on PMD behaviour. Methods: Retrospective review of 590 PMD patients treated in Northern England by CO2 laser between 1996 & 2014 with known clinical outcome. Lesions exhibiting PVL or LI were identified from a previously published database & the influence of clinico-pathological features on outcome analyzed. Results: 80 PVL & 118 LI cases were seen, predominantly leukoplakias on ventro-lateral tongue & floor of mouth, equally distributed between males & females. Most showed dysplasia on incision biopsy (85% PVL; 82% LI) & were treated by laser excision rather than ablation (86.25% PVL; 88.1% LI). LIs were more common in younger patients (PVL mean age 62.25yrs; LI mean age 57.1yrs; p=0.008) & more likely to present as erythroleukoplakia (PVL 2.5%; LI 15.3%; p=0.003). No significant clinical outcome differences were seen with 65% PVL & 69.5% LI disease free at study census (p=0.55), although less than overall PMD disease free status (74.2%)1. 2 PVLs (2.5%) & 2 LIs (1.7%) underwent MT. Conclusions: One-third of PMD cases exhibited PVL or LI with reduced disease free status, with LIs distinguishable as erythroleukoplakia in younger patients. MT is infrequent following interventional laser excision.-
dc.languageeng-
dc.publisherInternational Association for Dental Research.-
dc.relation.ispartofIADR/PER General Session & Exhibition, 2018-
dc.titlePotentially malignant disorder behaviour – Proliferative Verrucous Leukoplakia vs Lichenoid Inflammation-
dc.typeConference_Paper-
dc.identifier.emailThomson, PJ: thomsonp@hku.hk-
dc.identifier.authorityThomson, PJ=rp02327-
dc.identifier.hkuros287331-
dc.identifier.hkuros296894-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats